Zinc in PDB 6vn6: USP7 in Complex with Ligand Compound 14

All present enzymatic activity of USP7 in Complex with Ligand Compound 14:
3.4.19.12;

The structure of USP7 in Complex with Ligand Compound 14, PDB code: 6vn6 was solved by P.R.Leger, D.J.Wustrow, D.X.Hu, S.Krapp, K.Maskos, M.Blaesse, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	47.90 / 2.99
Space group	P 1 21 1
Cell size a, b, c (Å), α, β, γ (°)	70.301, 65.680, 85.313, 90.00, 94.04, 90.00
R / Rfree (%)	21.9 / 26.7

The structure of USP7 in Complex with Ligand Compound 14 also contains other interesting chemical elements:

Chlorine

(Cl)

4 atoms

The binding sites of Zinc atom in the USP7 in Complex with Ligand Compound 14 (pdb code 6vn6). This binding sites where shown within 5.0 Angstroms radius around Zinc atom.
In total 2 binding sites of Zinc where determined in the USP7 in Complex with Ligand Compound 14, PDB code: 6vn6:
Jump to Zinc binding site number: 1; 2;

Zinc binding site 1 out of 2 in the USP7 in Complex with Ligand Compound 14


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 1 of USP7 in Complex with Ligand Compound 14 within 5.0Å range: probe atom residue distance (Å) B Occ A:Zn602 b:95.2 occ:1.00 OD1 A:ASP349 2.0 0.2 1.0 ND1 A:HIS403 2.1 77.7 1.0 SG A:CYS300 2.3 89.6 1.0 CE1 A:HIS403 3.0 79.3 1.0 CG A:ASP349 3.1 81.4 1.0 CG A:HIS403 3.1 73.4 1.0 CB A:HIS403 3.5 63.8 1.0 CB A:CYS300 3.5 75.2 1.0 OD2 A:ASP349 3.6 88.6 1.0 NE2 A:HIS403 4.1 76.0 1.0 CD2 A:HIS403 4.2 70.0 1.0 CB A:ASP349 4.4 79.1 1.0 CE A:MET515 4.4 64.8 1.0 NE2 A:GLN405 4.4 75.4 1.0 O A:TYR348 4.4 86.5 1.0 CD1 A:LEU304 4.6 74.7 1.0 CA A:CYS300 4.8 69.0 1.0 CA A:HIS403 5.0 63.0 1.0

Zinc binding site 2 out of 2 in the USP7 in Complex with Ligand Compound 14


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 2 of USP7 in Complex with Ligand Compound 14 within 5.0Å range: probe atom residue distance (Å) B Occ B:Zn602 b:99.5 occ:1.00 OD1 B:ASP349 2.0 0.6 1.0 ND1 B:HIS403 2.1 82.3 1.0 SG B:CYS300 2.3 98.1 1.0 CE1 B:HIS403 3.0 83.7 1.0 CG B:HIS403 3.1 79.2 1.0 CG B:ASP349 3.1 0.5 1.0 CB B:HIS403 3.4 79.6 1.0 CB B:CYS300 3.4 89.6 1.0 OD2 B:ASP349 3.6 0.2 1.0 NE2 B:HIS403 4.1 77.2 1.0 CD2 B:HIS403 4.2 73.5 1.0 CE B:MET515 4.3 89.2 1.0 NE2 B:GLN405 4.3 92.2 1.0 CB B:ASP349 4.3 98.7 1.0 O B:TYR348 4.4 93.1 1.0 CD1 B:LEU304 4.7 64.2 1.0 CA B:CYS300 4.8 89.5 1.0 CA B:HIS403 5.0 74.2 1.0

P.R.Leger, D.X.Hu, B.Biannic, M.Bui, X.Han, E.Karbarz, J.Maung, A.Okano, M.Osipov, G.M.Shibuya, K.Young, C.Higgs, B.Abraham, D.Bradford, C.Cho, C.Colas, S.Jacobson, Y.M.Ohol, D.Pookot, P.Rana, J.Sanchez, N.Shah, M.Sun, S.Wong, D.G.Brockstedt, P.D.Kassner, J.B.Schwarz, D.J.Wustrow. Discovery of Potent, Selective, and Orally Bioavailable Inhibitors of USP7 with in Vivo Anti-Tumor Activity. J.Med.Chem. 2020.
ISSN: ISSN 0022-2623
PubMed: 32302140
DOI: 10.1021/ACS.JMEDCHEM.0C00245